Market News AIOpen the app

UBS raised its price target for DocuSign to $85 from $70 but still has a neutral rating.

OpinionRead the original at marketscreener.com
Neutral

UBS raised its target from $70 to $85 but kept its neutral rating. The report adds an analyst view, not new business results, so DocuSign's outlook is unchanged.

DOCU · DocuSign, Inc.

AI read · Neutral

The AI's read

A higher target suggests UBS sees more room for the shares, but its unchanged rating shows it did not shift to a positive view. The report gives no new sales, profit, or product news, so it does not change DocuSign's business outlook.

Get alerts for DOCU

Follow DocuSign, Inc. (DOCU) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DOCU
Free on the App Store and Google Play, or on the web.